Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Biochemical Pharmacology|May 8, 2022
A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivoYin-Ru Li, Fang-Fang Liu, Wen-Bo Liu, et al.Journal of Cancer Research and Clinical Oncology|April 17, 2021
A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expressionHong-Li Li, Qian-Yu Li, Min-Jie Jin, et al.European Journal of Medicinal Chemistry|March 7, 2023
Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatmentQi-Sheng Ma, Yi-Fan Zhang, Cheng-Yang Li, et al.European Journal of Medicinal Chemistry|November 12, 2022
New drug approvals for 2021: Synthesis and clinical applicationsShuo Yuan, Dan-Shu Wang, Hui Liu, et al.Environmental Toxicology|December 31, 2020
Ras/Raf/MEK/ERK pathway axis mediated neurotoxicity induced by high-risk pesticide residue-AvermectinTing Zhu, Xu Liu, Jian Song, et al.Bioorganic & Medicinal Chemistry Letters|May 20, 2025
Discovery of novel coumarin-sulfonates as tubulin polymerization inhibitors targeting the colchicine-binding site with potent anticancer activitiesDan Zhao, Ji Wu, Jing-Sai Song, et al.Bioorganic Chemistry|February 21, 2023
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapyXiu-Juan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.European Journal of Medicinal Chemistry|July 14, 2022
Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathwayJian Song, Sheng-Hui Wang, Chun-Hong Song, et al.European Journal of Medicinal Chemistry|August 29, 2021
Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancersJian Song, Yuan Liu, Xin-Ying Yuan, et al.European Journal of Medicinal Chemistry|August 16, 2024
Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistanceXiang-Jing Fu, Na Li, Ji Wu, et al.Pageof 7